MedPath

Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association

Conditions
Trauma
Inflammation
Registration Number
NCT03622632
Lead Sponsor
Hopital du Sacre-Coeur de Montreal
Brief Summary

The goal of this project, is to better understand the fluctuation of the level of uric acid in traumatized patients by making serial measurements during their hospitalization in the intensive care unit. In addition, the determinants (e.g. type of trauma, diseases, interventions) of the blood level of uric acid and its association with the development of organ failure will be sought.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Direct admission to trauma center
  • ≤ 3h after trauma
  • ISS ≥ 16
  • Received at least 1L of fluid at ER entrance
Exclusion Criteria
  • Isolated head injury
  • Isolated spine injury
  • Chemotherapy within the last month
  • Hematologic disease
  • Chronic hemodialysis
  • Uricase treatment within the last week
  • Expected death within 48h

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of serial plasmatic uric acid sampling after trauma7 days

Number of measures collected/number of measures planned

Secondary Outcome Measures
NameTimeMethod
Clinical predictors of the first blood uric acid (μmol/L) level measured12 hours

Impact of patient's characteristics and physiological variables on the first measured blood uric acid.

Characteristics will include: age (years), gender, Injury severity score, presence of acute renal impairment.

Physiological variables will include: lower systolic blood pressure, base deficit, lactate level

Impact of resuscitation on uric acid measures24 to 48 hours

Impact of fluid administration (amount in mL) on the changes of subsequent uric acid blood level

Trial Locations

Locations (1)

Hôpital du Sacré-Cœur de Montréal

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath